EyePoint Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EYPT and other ETFs, options, and stocks.

About EYPT

EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. 

CEO
Jay S. Duker
CEOJay S. Duker
Employees
165
Employees165
Headquarters
Watertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded
1987
Founded1987
Employees
165
Employees165

EYPT Key Statistics

Market cap
647.52M
Market cap647.52M
Price-Earnings ratio
-3.91
Price-Earnings ratio-3.91
Dividend yield
—
Dividend yield—
Average volume
860.90K
Average volume860.90K
High today
$9.99
High today$9.99
Low today
$9.36
Low today$9.36
Open price
$9.70
Open price$9.70
Volume
571.90K
Volume571.90K
52 Week high
$13.99
52 Week high$13.99
52 Week low
$3.91
52 Week low$3.91

Analyst ratings

100%

of 13 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own EYPT. This list is generated using Robinhood data, and it’s not a recommendation.
SoundHound AI
Plug Power
Riot Platforms
ChargePoint
FuelCell Energy
Tilray Brands
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.